Namitecan

DB12124InvestigationalSmall molecule

Namitecan has been used in trials studying the treatment of Solid Tumors.

Chemical structure of Namitecan
Formula / weight
C23H22N4O5 · 434.452 g/mol (avg)

Resolves to

Compound
UNIIX34Z8N66T3CAS372105-27-6ChEMBLCHEMBL419186PubChem10950142
Structure
InChIKeyIBTISPLPBBHVSU-UVOOVGFISA-NSMILESCC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C1N=C1C=CC=CC1=C3\C=N\OCCN)C2=O
Targets
P11387TOP1

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
39Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Namitecan, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In